Established since 2006, we operate solely within the Pharma, Biotech and Medical Device industries. We work in partnership with a wide range of clients, from blue-chip manufacturers to specialist boutique consultancies, supporting them all in finding talented individuals for their permanent and contract vacancies. If you are looking to attract new people to your team or you’re a candidate looking for a new opportunity, then we’d love to hear from you.
Our expertise runs right through the product lifecycle and our Consultant teams are split out by sector, meaning that they are very specialised in what they do with strong networks and excellent knowledge of their specific markets. The sectors we work across include:
You can find out more about the roles we cover here. And if you can’t find what you’re looking for or have any questions whatsoever, please don’t hesitate to call us on +44 (0)1625 541 030 and the team will be very happy to help.
This year, we've partnered with the fantastic Children's Farm Trust as our corporate charity. Find out more about how the money we raise can help them - and why we're walking to New Zealand and back to do so - here!
No CV? No problem! Use “Apply with Linked In” when you apply for jobs and it magically sends us your profile.
We can’t find you a fab new job if you don’t... And we’d never do anything naughty with your info.
Image from rawpixel.com
By Jon Morris, specialist Market Access consultant
What is Market Access?
Market Access is essentially the way pharmaceutical companies allow their products to enter the market, across various countries and regions, in order to reach and benefit patients. Market Access is focused around demonstrating the value of these products in order to gain access to and supply of the National Health Service of a country, after which pharmaceutical companies are then reimbursed as the product is used by patients.
Market Access is a niche, yet ever expanding market within pharmaceuticals. There is a growing need for strong talent within the sector. I believe the only way to continue this growth will be to invest in graduate and entry-level Market Access roles. There are a couple of reasons for this, most prominent being that Market Access is such a niche area of pharma that it can be quite difficult to transfer into the sector from a different pharma-based role, meaning the best way in is to start in an entry level position and work your way up.
So how do I go about a career within Market Access?
I come across many candidates who are interested in working within Market Access but who don't know exactly what the sector consists of or what degree / skill-set they need in order to get their foot in the door. One element the majority of pharmaceutical companies or pharmaceutical consultancies look for is a strong academic background and an interest in life sciences. Usually a MSc, PharmD or PhD in a life science related degree is required for an application, but not always.
Market Access, particularly when working on behalf of a consultancy, will usually involve working on projects from around the world. As a result of this, languages are always an advantage for a consultancy to have in-house, so if you can speak a different language or two this will stand you in good stead.
Relevant experience is always a plus when employers are looking for graduate or entry-level candidates. For example, if you have worked in a pharmacy, pharmaceutical company, pharmaceutical consultancy or in medicine previously this would be advantageous, but again this is not always essential.
Some of the main components of experience that will be beneficial are strong analytical skills, excellent communication skills, research experience, ability to work with complex data and being able to deliver an excellent service to clients.
There are a variety of doors that will open once you begin your career in pharmaceuticals. The usual career ladder for Market Access is as follows:
There is no definitive tick list of experience or credentials that are required to get yourself into the Market Access space, but I hope my guide above will give some help to people interested in a career within this exciting sector.
I wish you the best of luck in your search and if you would like a conversation regarding positions available - please feel free to get in touch!
+44 (0)1625 541 047 / [email protected]
Our specialist Market Access recruitment consultants have recently returned from the annual ISPOR Europe conference, which was held in beautiful Copenhagen.
Chris Costello reflects on his time at the health economics and outcomes research convention:
Now the dust is settling after another year at ISPOR 2019 in Copenhagen I thought I'd just share a few thoughts & perceptions on this.
Carrot Pharma Recruitment's Healthcare Communications team are back in the office after a fantastic couple of days in London and a very successful industry get together. It was great to meet so many of our London based contacts, whom we usually only get the opportunity to speak with over the phone. The evening had a fantastic atmosphere with delicious food and drink from Dirty Martini, and spellbinding magic from Magio.
The evening was attended by Medical Communications, Healthcare Advertising & PR, Healthcare Market Research and Market Access professionals. There were plenty of discussions surrounding industry news and developments as well as the ability for us to learn more about the exciting projects people are involved with. It's always good to be able to put a face to a name and it was a joy to have the chance to chat to so many professionals from the industry in such an informal and fun setting.
We'd like to say a huge thank you to everyone who attended from all the sectors that were represented. If anyone has anything they wish to discuss further, then please do get in touch with us - all our specialist recruitment consultants' contact details are below:
We hope to see you all again next year!
Healthcare Communications Consultants:
Market Research Consultants:
Market Access Consultants:
For all our roles within pharma, healthcare and devices click here.
Biogen have said that their drug, aducanumab, can 'reduce clinical decline' of patients in the early stages of Alzheimer's if it is approved.
As agreement between Vertex and NHS England has been signed which covers all of Vertex's licensed cystic fibrosis medicines.
For the second time this year Astrazenaca has raised its annual drug sales forcecase due to an increase in sales from new cancer treatments.
A third of sexually active British men say they would consider taking a hormonal form of contraception which is the same percentage of British women who currently use such medication.
The final phase of the NHS' Electronic Prescription Service (EPS) roll-out is set to go live on November 18, beginning with GP practices using the TPP SystmOne system.
The world's first Ebola vaccine, developed by Merck & Co, has been approved by the European drugs regulator. The decision could save many lives and is already being used under emergency guidelines in the Democratic Republic of Congo.
GPOline has reported that in September 2019, 1855 GPs had an active case with the initiative that offers free confidential support for doctors and dentists in England. This is compared to 1,188 GPs at the end of the first quarter of the 2018/19 financial year
BMS and Pfizer have announced at the TIME 100 Health Summit in New York that they are working with Fitbit to deliver timely atrial fibrillation diagnosis. This is to aim to improve the detection of individuals who have an increased risk of a stroke.
Is there an alternative to pharmaceutical companies making drugs? Well, one Dutch chemist thinks so.
The pharma giant has lost half a billion dollars in brand value over the past year, according to Interbrand's Best Global Brands for 2019 ranking. This is the first time since 2011 that J&J has shed value in the survey, and it appears to be due to a number of ongoing lawsuits against the company.